Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mesoblast Ltd (NASDAQ:MESO)

6.81
Delayed Data
As of Oct 18
 -0.06 / -0.87%
Today’s Change
4.01
Today|||52-Week Range
12.50
+27.29%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close6.87
Today’s open6.71
Day’s range6.70 - 6.81
Volume21,915
Average volume (3 months)32,336
Market cap$632.9M
Dividend yield--
Data as of 10/18/2017

Growth & Valuation

Earnings growth (last year)-1,605.50%
Earnings growth (this year)+1.28%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-95.31%
P/E ratio--
Price/Sales326.56
Price/Book1.14

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp-0.10-0.68%
RTIXRTI Surgical Inc+0.05+1.05%
SIENSientra Inc-0.19-1.21%
OFIXOrthofix Internation...+0.37+0.76%
Data as of 10/18/2017

Financials

Next reporting dateDecember 20, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$1.9M
Annual profit (last year)-$76.8M
Net profit margin-3,951.39%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts